NCT06231836View on ClinicalTrials.gov

High-flow Nasal Oxygenation Versus Standard Oxygenation for Gastrointestinal Endoscopy With Sedation in Obese Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 20, 2024

Primary Completion Date

July 20, 2024

Study Completion Date

July 20, 2024

Conditions
Prevention of Intraoperative Hypoxia
Interventions
DEVICE

High flow nasal cannula (HFNO)

O2 is administered by HFNO with flow 70L/min and the FiO2 is set at 40%,

DEVICE

nasal cannula

O2 is administered by nasal cannula at 6L/min

Trial Locations (1)

20

Ain shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06231836 - High-flow Nasal Oxygenation Versus Standard Oxygenation for Gastrointestinal Endoscopy With Sedation in Obese Patients | Biotech Hunter | Biotech Hunter